Stocks and Investing
Stocks and Investing
Thu, April 30, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, April 29, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jessica Fye Maintained (UTHR) at Hold with Increased Target to $158 on, Apr 29th, 2015
Jessica Fye of JP Morgan, Maintained "United Therapeutics Corporation" (UTHR) at Hold with Increased Target from $147 to $158 on, Apr 29th, 2015.
Jessica has made no other calls on UTHR in the last 4 months.
There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 2 agree with Jessica's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Initiated at Hold and Held Target at $135 on, Tuesday, January 6th, 2015
- Julian Harrison of "BTIG" Initiated at Hold on, Tuesday, January 6th, 2015
This is the rating of the analyst that currently disagrees with Jessica
- Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Thursday, March 12th, 2015